{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:06:41Z","timestamp":1788926801948,"version":"build-2803163510"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01978-7","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:35:07Z","timestamp":1788924907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postbiotics as a therapeutic frontier in Parkinson\u2019s disease: Insights into molecular pathways and neuroprotective effects"],"prefix":"10.1007","volume":"41","author":[{"given":"Anjali","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"1978_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-025-01498-x","author":"AE Abreu","year":"2025","unstructured":"Abreu AE, Empadinhas N, Cardoso SM (2025) Unveiling butyrate as a Parkinson\u2019s disease therapy. Neurosci Bull. https:\/\/doi.org\/10.1007\/s12264-025-01498-x","journal-title":"Neurosci Bull"},{"issue":"1","key":"1978_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VT Aho","year":"2021","unstructured":"Aho VT, Houser MC, Pereira PA, Chang J, Rudi K, Paulin L, Hertzberg V, Auvinen P, Tansey MG, Scheperjans F (2021) Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol Neurodegener 16(1):6. https:\/\/doi.org\/10.1186\/s13024-021-00427-6","journal-title":"Mol Neurodegener"},{"key":"1978_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1496616","volume":"11","author":"M Alam","year":"2024","unstructured":"Alam M, Abbas K, Mustafa M, Usmani N, Habib S (2024) Microbiome-based therapies for Parkinson\u2019s disease. Front Nutr 11:1496616. https:\/\/doi.org\/10.3389\/fnut.2024.1496616","journal-title":"Front Nutr"},{"key":"1978_CR4","doi-asserted-by":"publisher","unstructured":"Alkuwaiti SH, Skrabulyte-Barbulescu J, Yassin LK, Almazrouei S, Aldhaheri D, Alderei M, BaniYas S, Alshamsi SH, Alnuaimi A, Saeed S, Alawadhi M (2025) Harnessing the microbiota-gut\u2013brain axis to prevent and treat pediatric neurodevelopmental disorders: translational insights and strategies. J Translational Med 11286. https:\/\/doi.org\/10.1186\/s12967-025-07279-4","DOI":"10.1186\/s12967-025-07279-4"},{"key":"1978_CR5","doi-asserted-by":"publisher","first-page":"102685","DOI":"10.1016\/j.arr.2025.102685","volume":"106","author":"KR Aran","year":"2025","unstructured":"Aran KR, Porel P, Hunjan G, Singh S, Gupta GD (2025) Postbiotics as a therapeutic tool in Alzheimer\u2019s disease: Insights into molecular pathways and neuroprotective effects. Ageing Res Rev 106:102685. https:\/\/doi.org\/10.1016\/j.arr.2025.102685","journal-title":"Ageing Res Rev"},{"key":"1978_CR6","doi-asserted-by":"publisher","first-page":"1699884","DOI":"10.3389\/fnut.2025.1699884","volume":"12","author":"N Auclair-Ouellet","year":"2025","unstructured":"Auclair-Ouellet N, Kassem O, Bronner S, Oula ML, Binda S (2025) Leveraging microbiome-based interventions to improve the management of neurodegenerative diseases: evidence for effects along the microbiota-gut-brain axis. Front Nutr 12:1699884. https:\/\/doi.org\/10.3389\/fnut.2025.1699884","journal-title":"Front Nutr"},{"key":"1978_CR7","doi-asserted-by":"publisher","unstructured":"Baek J, Lee S, Lee J, Park J, Choi E, Kang SS (2024) Utilization of probiotic-derived extracellular vesicles as postbiotics and their role in mental health therapeutics. Korean J Food Sci Anim Resour 61252\u20131265. https:\/\/doi.org\/10.5851\/kosfa.2024.e92","DOI":"10.5851\/kosfa.2024.e92"},{"issue":"4","key":"1978_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041623","volume":"22","author":"D Banfi","year":"2021","unstructured":"Banfi D, Moro E, Bosi A, Bistoletti M, Cerantola S, Crema F, Maggi F, Giron MC, Giaroni C, Baj A (2021) Impact of microbial metabolites on microbiota\u2013gut\u2013brain axis in inflammatory bowel disease. Int J Mol Sci 22(4):1623. https:\/\/doi.org\/10.3390\/ijms22041623","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1978_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.gpb.2021.08.009","volume":"20","author":"A Becker","year":"2022","unstructured":"Becker A, Schmartz GP, Gr\u00f6ger L, Grammes N, Galata V, Philippeit H, Weiland J, Ludwig N, Meese E, Tierling S, Walter J (2022) Effects of resistant starch on symptoms, fecal markers, and gut microbiota in Parkinson\u2019s disease\u2014the RESISTA-PD trial. Genomics Proteomics Bioinformatics 20(2):274\u201387. https:\/\/doi.org\/10.1016\/j.gpb.2021.08.009","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"1","key":"1978_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41531-025-00885-5","volume":"11","author":"JR Bedarf","year":"2025","unstructured":"Bedarf JR, Romano S, Heinzmann SS, Duncan A, Traka MH, Ng D, Segovia-Lizano D, Simon MC, Narbad A, W\u00fcllner U, Hildebrand F (2025) A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson\u2019s Disease. npj Parkinson\u2019s Disease 11(1):66. https:\/\/doi.org\/10.1038\/s41531-025-00885-5","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"1","key":"1978_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/mds.27895","volume":"35","author":"G Bellomo","year":"2020","unstructured":"Bellomo G, Paciotti S, Gatticchi L, Parnetti L (2020) The vicious cycle between \u03b1-synuclein aggregation and autophagic\u2010lysosomal dysfunction. Mov Disord 35(1):34\u201344. https:\/\/doi.org\/10.1002\/mds.27895","journal-title":"Mov Disord"},{"issue":"1","key":"1978_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1196\/annals.1397.081","volume":"1096","author":"H Bielau","year":"2007","unstructured":"Bielau H, Steiner J, Mawrin C, Truebner K, Brisch R, MEYER-LOTZ GA, Brodhun M, Dobrowolny H, Baumann B, Gos T, BERNSTEIN HG (2007) Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study. Ann N Y Acad Sci 1096(1):157\u2013169. https:\/\/doi.org\/10.1196\/annals.1397.081","journal-title":"Ann N Y Acad Sci"},{"key":"1978_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01452","volume":"8","author":"B Bonaz","year":"2017","unstructured":"Bonaz B, Sinniger V, Pellissier S (2017) The vagus nerve in the neuro-immune axis: implications in the pathology of the gastrointestinal tract. Front Immunol 8:1452. https:\/\/doi.org\/10.3389\/fimmu.2017.01452","journal-title":"Front Immunol"},{"issue":"1","key":"1978_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41538-024-00253-2","volume":"8","author":"JD Braga","year":"2024","unstructured":"Braga JD, Thongngam M, Kumrungsee T (2024) Gamma-aminobutyric acid as a potential postbiotic mediator in the gut\u2013brain axis. npj Sci Food 8(1):16. https:\/\/doi.org\/10.1038\/s41538-024-00253-2","journal-title":"npj Sci Food"},{"key":"1978_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/frfst.2025.1692683","volume":"5","author":"X Chen","year":"2025","unstructured":"Chen X, Yuan C, He J, Li W, Liao C (2025) Current research status and trends in the bioactivity of postbiotics. Front Food Sci Technol 5:1692683. https:\/\/doi.org\/10.3389\/frfst.2025.1692683","journal-title":"Front Food Sci Technol"},{"key":"1978_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fnins.2019.00560","volume":"13","author":"E Colla","year":"2019","unstructured":"Colla E (2019) Linking the endoplasmic reticulum to Parkinson\u2019s disease and alpha-synucleinopathy. Front NeuroSci 13:560. https:\/\/doi.org\/10.3389\/fnins.2019.00560","journal-title":"Front NeuroSci"},{"issue":"1","key":"1978_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","volume":"39","author":"HN Costa","year":"2023","unstructured":"Costa HN, Esteves AR, Empadinhas N, Cardoso SM (2023) Parkinson\u2019s disease: a multisystem disorder. Neurosci Bull 39(1):113\u2013124. https:\/\/doi.org\/10.1007\/s12264-022-00934-6","journal-title":"Neurosci Bull"},{"issue":"11","key":"1978_CR18","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.1002\/jsfa.13370","volume":"104","author":"VL Dasriya","year":"2024","unstructured":"Dasriya VL, Samtiya M, Ranveer S, Dhillon HS, Devi N, Sharma V, Nikam P, Puniya M, Chaudhary P, Chaudhary V, Behare PV (2024) Modulation of gut-microbiota through probiotics and dietary interventions to improve host health. J Sci Food Agric 104(11):6359\u20136375. https:\/\/doi.org\/10.1002\/jsfa.13370","journal-title":"J Sci Food Agric"},{"issue":"4","key":"1978_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinson\u2019s disease 3(4):461\u2013491. https:\/\/doi.org\/10.3233\/JPD-130230","journal-title":"J Parkinson\u2019s disease"},{"issue":"1","key":"1978_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01029-5","volume":"11","author":"WX Duan","year":"2025","unstructured":"Duan WX, Xie WY, Ying C, Fen W, Cheng XY, Mao CJ, Liu JY, Liu CF (2025) Butyrate improves abnormal sleep architecture in a Parkinson\u2019s disease mouse model via BDNF\/TrkB signaling. NPJ Parkinsons Dis 11(1):175. https:\/\/doi.org\/10.1038\/s41531-025-01029-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"1978_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5056\/jnm19044","volume":"25","author":"SK Dutta","year":"2019","unstructured":"Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP (2019) Parkinson\u2019s disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation. J Neurogastroenterol Motil 25(3):363. https:\/\/doi.org\/10.5056\/jnm19044","journal-title":"J Neurogastroenterol Motil"},{"issue":"1","key":"1978_CR22","doi-asserted-by":"publisher","first-page":"1801944","DOI":"10.1080\/19490976.2020.1801944","volume":"12","author":"T Feng","year":"2020","unstructured":"Feng T, Wang J (2020) Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review. Gut Microbes 12(1):1801944. https:\/\/doi.org\/10.1080\/19490976.2020.1801944","journal-title":"Gut Microbes"},{"key":"1978_CR23","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Moriano C, Gonz\u00e1lez\u2010Burgos E, G\u00f3mez\u2010Serranillos MP (2017) Lipid peroxidation and mitochondrial dysfunction in alzheimer\u2019s and Parkinson\u2019s diseases: role of natural products as cytoprotective agents. Neuroprotective Natural Products: Clinical Aspects and Mode of Action. 107\u2009\u2013\u200951. https:\/\/doi.org\/10.1002\/9783527803781.ch6","DOI":"10.1002\/9783527803781.ch6"},{"issue":"1","key":"1978_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/apt.14689","volume":"48","author":"PA Gill","year":"2018","unstructured":"Gill PA, Van Zelm MC, Muir JG, Gibson PR (2018) Short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Aliment Pharmacol Ther 48(1):15\u201334. https:\/\/doi.org\/10.1111\/apt.14689","journal-title":"Aliment Pharmacol Ther"},{"issue":"14","key":"1978_CR25","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3390\/nu16142244","volume":"16","author":"P G\u0142owacka","year":"2024","unstructured":"G\u0142owacka P, Oszajca K, Pudlarz A, Szemraj J, Witusik-Perkowska M (2024) Postbiotics as molecules targeting cellular events of aging brain\u2014the role in pathogenesis, prophylaxis and treatment of neurodegenerative diseases. Nutrients 16(14):2244. https:\/\/doi.org\/10.3390nu16142244","journal-title":"Nutrients"},{"key":"1978_CR26","doi-asserted-by":"publisher","first-page":"102165","DOI":"10.1016\/j.redox.2021.102165","volume":"47","author":"C Gonz\u00e1lez-Bosch","year":"2021","unstructured":"Gonz\u00e1lez-Bosch C, Boorman E, Zunszain PA, Mann GE (2021) Short-chain fatty acids as modulators of redox signaling in health and disease. Redox Biol 47:102165. https:\/\/doi.org\/10.1016\/j.redox.2021.102165","journal-title":"Redox Biol"},{"issue":"1","key":"1978_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00271-0","volume":"10","author":"AM Gorecki","year":"2021","unstructured":"Gorecki AM, Anyaegbu CC, Anderton RS (2021) TLR2 and TLR4 in Parkinson\u2019s disease pathogenesis: the environment takes a toll on the gut. Transl Neurodegener 10(1):47. https:\/\/doi.org\/10.1186\/s40035-021-00271-0","journal-title":"Transl Neurodegener"},{"issue":"9","key":"1978_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094508","volume":"23","author":"E Guatteo","year":"2022","unstructured":"Guatteo E, Berretta N, Monda V, Ledonne A, Mercuri NB (2022) Pathophysiological features of nigral dopaminergic neurons in animal models of Parkinson\u2019s disease. Int J Mol Sci 23(9):4508. https:\/\/doi.org\/10.3390\/ijms23094508","journal-title":"Int J Mol Sci"},{"key":"1978_CR29","doi-asserted-by":"publisher","unstructured":"Gupta MK, Chauhan K, Bhardwaj S, Srivastava R (2025) Innovative Interventions: Postbiotics and Psychobiotics in Neurodegenerative Disease Treatment. Probiotics and Antimicrobial Proteins. 1\u201320. https:\/\/doi.org\/10.1007\/s12602-025-10632-0","DOI":"10.1007\/s12602-025-10632-0"},{"key":"1978_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","volume":"51","author":"DN Hauser","year":"2013","unstructured":"Hauser DN, Hastings TG (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic parkinsonism. Neurobiol Dis 51:35\u201342. https:\/\/doi.org\/10.1016\/j.nbd.2012.10.011","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1978_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-020-00368-6","volume":"15","author":"BA Hijaz","year":"2020","unstructured":"Hijaz BA, Volpicelli-Daley LA (2020) Initiation and propagation of \u03b1-synuclein aggregation in the nervous system. Mol neurodegeneration 15(1):19. https:\/\/doi.org\/10.1186\/s13024-020-00368-6","journal-title":"Mol neurodegeneration"},{"issue":"10","key":"1978_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105441","volume":"25","author":"E Hijov\u00e1","year":"2024","unstructured":"Hijov\u00e1 E (2024) Postbiotics as metabolites and their biotherapeutic potential. Int J Mol Sci 25(10):5441. https:\/\/doi.org\/10.3390\/ijms25105441","journal-title":"Int J Mol Sci"},{"issue":"Suppl. 2","key":"1978_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000518147","volume":"77","author":"M Hirayama","year":"2021","unstructured":"Hirayama M, Ohno K (2021) Parkinson\u2019s disease and gut microbiota. Ann Nutr Metab 77(Suppl. 2):28\u201335. https:\/\/doi.org\/10.1159\/000518147","journal-title":"Ann Nutr Metab"},{"issue":"5","key":"1978_CR34","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1007\/s11947-024-03701-9","volume":"18","author":"A Homayouni-Rad","year":"2025","unstructured":"Homayouni-Rad A, Pouragha B, Houshyar J, Soleimani RA, Kazemi S, Keisan S, Akhlaghi A (2025) Postbiotic application: a review on extraction, purification, and characterization methods. Food Bioprocess Technol 18(5):4153\u20134174. https:\/\/doi.org\/10.1007\/s11947-024-03701-9","journal-title":"Food Bioprocess Technol"},{"key":"1978_CR35","doi-asserted-by":"publisher","first-page":"615075","DOI":"10.3389\/fcimb.2021.615075","volume":"11","author":"Y Huang","year":"2021","unstructured":"Huang Y, Liao J, Liu X, Zhong Y, Cai X, Long L (2021) The role of intestinal dysbiosis in Parkinson\u2019s disease. Front Cell Infect Microbiol 11:615075. https:\/\/doi.org\/10.3389\/fcimb.2021.615075","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1978_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00726-022-03123-x","volume":"54","author":"NP Hyland","year":"2022","unstructured":"Hyland NP, Cavanaugh CR, Hornby PJ (2022) Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function. Amino Acids 54(1):57\u201370. https:\/\/doi.org\/10.1007\/s00726-022-03123-x","journal-title":"Amino Acids"},{"issue":"9","key":"1978_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/14728222.2021.1991913","volume":"25","author":"J Hyttinen","year":"2021","unstructured":"Hyttinen J, Blasiak J, Tavi P, Kaarniranta K (2021) Therapeutic potential of PGC-1\u03b1 in age-related macular degeneration (AMD)\u2013the involvement of mitochondrial quality control, autophagy, and antioxidant response. Expert Opin Ther Targets 25(9):773\u201385. https:\/\/doi.org\/10.1080\/14728222.2021.1991913","journal-title":"Expert Opin Ther Targets"},{"issue":"7","key":"1978_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T (2023) Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells 12(7):1012. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"issue":"1","key":"1978_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05611-z","volume":"63","author":"M Iyer","year":"2026","unstructured":"Iyer M, Kinoshita M, Reddy DH, Babu HW, Lakhanpal V, Yadav MK, Krishnan J, Palanivel V, Faris S, Chauhan K, Vellingiri B (2026) Deciphering the PGC-1\u03b1-TFAM axis in Parkinson\u2019s disease (PD)\u2014a mechanism approach targeting therapeutics for PD. Mol Neurobiol 63(1):329. https:\/\/doi.org\/10.1007\/s12035-025-05611-z","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1978_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/1570159X16666180302115032","volume":"17","author":"S Jamwal","year":"2019","unstructured":"Jamwal S, Kumar P (2019) Insight into the emerging role of striatal neurotransmitters in the pathophysiology of Parkinson\u2019s disease and Huntington\u2019s disease: a review. Curr Neuropharmacol 17(2):165\u2013175. https:\/\/doi.org\/10.2174\/1570159X16666180302115032","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"1978_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91(8):795\u2013808. https:\/\/doi.org\/10.1136\/jnnp-2019-322338","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"1978_CR42","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/kjm2.12745","volume":"39","author":"LL Ji","year":"2023","unstructured":"Ji LL, Huang TT, Mao LL, Xu YF, Chen WY, Wang WW, Wang LH (2023) The gut microbiota metabolite butyrate mitigates MPTP\/MPP+-induced Parkinson\u2019s disease by inhibiting the JAK2\/STAT3 signaling pathway. Kaohsiung J Med Sci 39(10):1002\u20131010. https:\/\/doi.org\/10.1002\/kjm2.12745","journal-title":"Kaohsiung J Med Sci"},{"key":"1978_CR43","doi-asserted-by":"publisher","first-page":"117708","DOI":"10.1016\/j.foodres.2025.117708","volume":"30","author":"L Jia","year":"2025","unstructured":"Jia L, Xiao L, Song X, Zhang X, Han X, Liang W, Fu T, Xie Y, Wang Y, Geng W (2025) Postbiotics alleviate cognitive impairment and neuroinflammation via gut-brain axis and TLR4\/MyD88\/NLRP3 pathway. Food Res Int 30:117708. https:\/\/doi.org\/10.1016\/j.foodres.2025.117708","journal-title":"Food Res Int"},{"key":"1978_CR44","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-24-01419","author":"T Ju","year":"2025","unstructured":"Ju T, Zhang Y, Liu L, Zhao X, Li X, Liu C, Sun S, Wu LA (2025) The role of gut microbiota\u2013mitochondria crosstalk in neurodegeneration: underlying mechanisms and potential therapies. Neural Regen Res. https:\/\/doi.org\/10.4103\/NRR.NRR-D-24-01419","journal-title":"Neural Regen Res"},{"key":"1978_CR45","doi-asserted-by":"publisher","first-page":"103092","DOI":"10.1016\/j.redox.2024.103092","volume":"71","author":"B Kalyanaraman","year":"2024","unstructured":"Kalyanaraman B, Cheng G, Hardy M (2024) Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: relevance to Parkinson\u2019s disease and therapeutic implications. Redox Biol 71:103092. https:\/\/doi.org\/10.1016\/j.redox.2024.103092","journal-title":"Redox Biol"},{"key":"1978_CR46","doi-asserted-by":"publisher","unstructured":"Kaur R, Mehan S, Singh S (2019) Understanding multifactorial architecture of Parkinson\u2019s disease: pathophysiology to management. Neurol Sci 113\u201323. https:\/\/doi.org\/10.1007\/s10072-018-3585-x","DOI":"10.1007\/s10072-018-3585-x"},{"issue":"3","key":"1978_CR47","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10753-024-02135-x","volume":"48","author":"R Kearns","year":"2025","unstructured":"Kearns R (2025) The kynurenine pathway in gut permeability and inflammation. Inflammation 48(3):1063\u20131077. https:\/\/doi.org\/10.1007\/s10753-024-02135-x","journal-title":"Inflammation"},{"key":"1978_CR48","doi-asserted-by":"publisher","first-page":"782082","DOI":"10.3389\/fnagi.2021.782082","volume":"13","author":"EM Klann","year":"2022","unstructured":"Klann EM, Dissanayake U, Gurrala A, Farrer M, Shukla AW, Ramirez-Zamora A, Mai V, Vedam-Mai V (2022) The gut\u2013brain axis and its relation to Parkinson\u2019s disease: a review. Front Aging Neurosci 13:782082. https:\/\/doi.org\/10.3389\/fnagi.2021.782082","journal-title":"Front Aging Neurosci"},{"issue":"17","key":"1978_CR49","doi-asserted-by":"publisher","first-page":"9197","DOI":"10.3390\/ijms25179197","volume":"25","author":"D Krawczuk","year":"2024","unstructured":"Krawczuk D, Groblewska M, Mroczko J, Winkel I, Mroczko B (2024) The role of \u03b1-synuclein in etiology of neurodegenerative diseases. Int J Mol Sci 25(17):9197. https:\/\/doi.org\/10.3390\/ijms25179197","journal-title":"Int J Mol Sci"},{"key":"1978_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2025.1690507","volume":"18","author":"I Kroker Kimber","year":"2025","unstructured":"Kroker Kimber I, Tremblay M\u00c8 (2025) Food for thought: probiotic modulation of microglial activity in Parkinson\u2019s disease. Front Mol Neurosci 18:1690507. https:\/\/doi.org\/10.3389\/fnmol.2025.1690507","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"1978_CR51","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1021\/acschemneuro.2c00730","volume":"14","author":"S Kumari","year":"2023","unstructured":"Kumari S, Taliyan R, Dubey SK (2023) Comprehensive review on potential signaling pathways involving the transfer of \u03b1-synuclein from the gut to the brain that leads to Parkinson\u2019s disease. ACS Chem Neurosci 14(4):590\u2013602. https:\/\/doi.org\/10.1021\/acschemneuro.2c00730","journal-title":"ACS Chem Neurosci"},{"key":"1978_CR52","doi-asserted-by":"publisher","unstructured":"Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, Yan J, Shi G (2021) Roles of \u03b1-synuclein in gastrointestinal microbiome dysbiosis-related Parkinson\u2019s disease progression. Mol Med Rep 4734. https:\/\/doi.org\/10.3892\/mmr.2021.12374","DOI":"10.3892\/mmr.2021.12374"},{"key":"1978_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainresbull.2020.12.009","volume":"168","author":"D Li","year":"2021","unstructured":"Li D, Bai X, Jiang Y, Cheng Y (2021) Butyrate alleviates PTZ-induced mitochondrial dysfunction, oxidative stress and neuron apoptosis in mice via Keap1\/Nrf2\/HO-1 pathway. Brain Res Bull 168:25\u201335. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.12.009","journal-title":"Brain Res Bull"},{"issue":"6","key":"1978_CR54","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s12602-023-10045-x","volume":"15","author":"B Liang","year":"2023","unstructured":"Liang B, Xing D (2023) The current and future perspectives of postbiotics. Probiotics Antimicrob proteins 15(6):1626\u20131643. https:\/\/doi.org\/10.1007\/s12602-023-10045-x","journal-title":"Probiotics Antimicrob proteins"},{"issue":"19","key":"1978_CR55","doi-asserted-by":"publisher","first-page":"9593","DOI":"10.3390\/ijms26199593","volume":"26","author":"Y Liang","year":"2025","unstructured":"Liang Y, Zhao Y, Fasano A, Su CW (2025) Gut Permeability and Microbiota in Parkinson\u2019s Disease: Mechanistic Insights and Experimental Therapeutic Strategies. Int J Mol Sci 26(19):9593. https:\/\/doi.org\/10.3390\/ijms26199593","journal-title":"Int J Mol Sci"},{"issue":"17","key":"1978_CR56","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037960","volume":"103","author":"J Liu","year":"2024","unstructured":"Liu J, Chen Q, Su R (2024) Interplay of human gastrointestinal microbiota metabolites: short-chain fatty acids and their correlation with Parkinson\u2019s disease. Medicine (Baltimore) 103(17):e37960. https:\/\/doi.org\/10.1097\/MD.0000000000037960","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1978_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LK, Ng CX, Chan HH, Yeow SH, Foo JB, Ong YS, How CW, Khaw KY (2024) Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target therapy 9(1):37. https:\/\/doi.org\/10.1038\/s41392-024-01743-1","journal-title":"Signal Transduct Target therapy"},{"key":"1978_CR58","doi-asserted-by":"publisher","first-page":"1348279","DOI":"10.3389\/fcimb.2024.1348279","volume":"14","author":"NU Mahbub","year":"2024","unstructured":"Mahbub NU, Islam MM, Hong ST, Chung HJ (2024) Dysbiosis of the gut microbiota and its effect on \u03b1-synuclein and prion protein misfolding: consequences for neurodegeneration. Front Cell Infect Microbiol 14:1348279. https:\/\/doi.org\/10.3389\/fcimb.2024.1348279","journal-title":"Front Cell Infect Microbiol"},{"issue":"13","key":"1978_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25136971","volume":"25","author":"J Maiuolo","year":"2024","unstructured":"Maiuolo J, Bulotta RM, Ruga S, Nucera S, Macr\u00ec R, Scarano F, Oppedisano F, Carresi C, Gliozzi M, Musolino V, Mollace R (2024) The postbiotic properties of butyrate in the modulation of the gut microbiota: the potential of its combination with polyphenols and dietary fibers. Int J Mol Sci 25(13):6971. https:\/\/doi.org\/10.3390\/ijms25136971","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1978_CR60","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s11064-016-2039-1","volume":"41","author":"R Maqsood","year":"2016","unstructured":"Maqsood R, Stone TW (2016) The gut-brain axis, BDNF, NMDA and CNS disorders. Neurochem Res 41(11):2819\u201335. https:\/\/doi.org\/10.1007\/s11064-016-2039-1","journal-title":"Neurochem Res"},{"key":"1978_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01934","volume":"7","author":"R Mazzoli","year":"2016","unstructured":"Mazzoli R, Pessione E (2016) The neuro-endocrinological role of microbial glutamate and GABA signaling. Front Microbiol 7:1934. https:\/\/doi.org\/10.3389\/fmicb.2016.01934","journal-title":"Front Microbiol"},{"key":"1978_CR62","doi-asserted-by":"publisher","first-page":"111661","DOI":"10.1016\/j.biopha.2021.111661","volume":"139","author":"R Mirzaei","year":"2021","unstructured":"Mirzaei R, Bouzari B, Hosseini-Fard SR, Mazaheri M, Ahmadyousefi Y, Abdi M, Jalalifar S, Karimitabar Z, Teimoori A, Keyvani H, Zamani F (2021) Role of microbiota-derived short-chain fatty acids in nervous system disorders. Biomed Pharmacother 139:111661. https:\/\/doi.org\/10.1016\/j.biopha.2021.111661","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1978_CR63","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41531-025-01142-5","volume":"11","author":"LH Morais","year":"2025","unstructured":"Morais LH, Stiles L, Freeman M, Oguienko AD, Hoang JD, Ji J, Jones J, Quan B, Devine J, Bois JS, Chou TF (2025) The gut microbiome promotes mitochondrial respiration in the brain of a Parkinson\u2019s disease mouse model. npj Parkinson\u2019s Disease 11(1):301. https:\/\/doi.org\/10.1038\/s41531-025-01142-5","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"2","key":"1978_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cimb47020089","volume":"47","author":"K Napi\u00f3rkowska-Baran","year":"2025","unstructured":"Napi\u00f3rkowska-Baran K, Treichel P, Dardzi\u0144ska A, Majcherczak A, Pilichowicz A, Szota M, Szymczak B, Alska E, Przybyszewska J, Bartuzi Z (2025) Immunomodulatory Effects of Selected Non-Nutritive Bioactive Compounds and Their Role in Optimal Nutrition. Curr Issues Mol Biol 47(2):89. https:\/\/doi.org\/10.3390\/cimb47020089","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"1978_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-020-01426-w","volume":"19","author":"BH Nataraj","year":"2020","unstructured":"Nataraj BH, Ali SA, Behare PV, Yadav H (2020) Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods. Microb Cell Fact 19(1):168. https:\/\/doi.org\/10.1186\/s12934-020-01426-w","journal-title":"Microb Cell Fact"},{"issue":"2","key":"1978_CR66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","volume":"11","author":"A Parker","year":"2020","unstructured":"Parker A, Fonseca S, Carding SR (2020) Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes 11(2):135\u201357. https:\/\/doi.org\/10.1080\/19490976.2019.1638722","journal-title":"Gut Microbes"},{"issue":"1","key":"1978_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s43094-025-00857-9","volume":"11","author":"AD Paul","year":"2025","unstructured":"Paul AD, Natarajan H (2025) From gut to brain: exploring the impact of microbiota, dysbiosis, and neuroinflammation in neurodegenerative disorders. Future J Pharm Sci 11(1):105. https:\/\/doi.org\/10.1186\/s43094-025-00857-9","journal-title":"Future J Pharm Sci"},{"key":"1978_CR68","doi-asserted-by":"publisher","first-page":"2515690X2095722","DOI":"10.1177\/2515690X2095722","volume":"25","author":"CT Peterson","year":"2020","unstructured":"Peterson CT (2020) Dysfunction of the microbiota-gut-brain axis in neurodegenerative disease: the promise of therapeutic modulation with prebiotics, medicinal herbs, probiotics, and synbiotics. J evidence-based Integr Med 25:2515690X20957225. https:\/\/doi.org\/10.1177\/2515690X2095722","journal-title":"J evidence-based Integr Med"},{"issue":"19","key":"1978_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199290","volume":"26","author":"EU Poluektova","year":"2025","unstructured":"Poluektova EU, Stavrovskaya A, Pavlova A, Yunes R, Marsova M, Koshenko T, Illarioshkin S, Danilenko V (2025) Gut microbiome as a source of probiotic drugs for Parkinson\u2019s disease. Int J Mol Sci 26(19):9290. https:\/\/doi.org\/10.3390\/ijms26199290","journal-title":"Int J Mol Sci"},{"key":"1978_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1306192","volume":"14","author":"N Prajapati","year":"2023","unstructured":"Prajapati N, Patel J, Singh S, Yadav VK, Joshi C, Patani A, Prajapati D, Sahoo DK, Patel A (2023) Postbiotic production: harnessing the power of microbial metabolites for health applications. Front Microbiol 14:1306192. https:\/\/doi.org\/10.3389\/fmicb.2023.1306192","journal-title":"Front Microbiol"},{"issue":"7","key":"1978_CR71","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/biom15070954","volume":"15","author":"SK Prajapati","year":"2025","unstructured":"Prajapati SK, Yadav D, Katiyar S, Jain S, Yadav H (2025) Postbiotics as Mitochondrial Modulators in Inflammatory Bowel Disease: Mechanistic Insights and Therapeutic Potential. Biomolecules 15(7):954. https:\/\/doi.org\/10.3390\/biom15070954","journal-title":"Biomolecules"},{"key":"1978_CR72","doi-asserted-by":"publisher","first-page":"127858","DOI":"10.1016\/j.micres.2024.127858","volume":"287","author":"S Qu","year":"2024","unstructured":"Qu S, Yu Z, Zhou Y, Wang S, Jia M, Chen T, Zhang X (2024) Gut microbiota modulates neurotransmitter and gut-brain signaling. Microbiol Res 287:127858. https:\/\/doi.org\/10.1016\/j.micres.2024.127858","journal-title":"Microbiol Res"},{"key":"1978_CR73","doi-asserted-by":"publisher","first-page":"100708","DOI":"10.1016\/j.jafr.2023.100708","volume":"14","author":"N Rafique","year":"2023","unstructured":"Rafique N, Jan SY, Dar AH, Dash KK, Sarkar A, Shams R, Pandey VK, Khan SA, Amin QA, Hussain SZ (2023) Promising bioactivities of postbiotics: A comprehensive review. J Agric Food Res 14:100708. https:\/\/doi.org\/10.1016\/j.jafr.2023.100708","journal-title":"J Agric Food Res"},{"issue":"1","key":"1978_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.70455","volume":"9","author":"A Ramesh","year":"2026","unstructured":"Ramesh A, Subbarayan R, Shrestha R, Adtani PN (2026) Exploring fecal microbiota transplantation: potential benefits, associated risks, and challenges in cancer treatment. Cancer Rep 9(1):e70455. https:\/\/doi.org\/10.1002\/cnr2.70455","journal-title":"Cancer Rep"},{"key":"1978_CR75","doi-asserted-by":"publisher","DOI":"10.2147\/NDS.S603490","author":"S Ranjbar","year":"2026","unstructured":"Ranjbar S, Asadollahi A, Ghanimati F, Rafie Sedaghat F, Samadi Kafil H (2026) Postbiotics as modulators of gut microbiota: therapeutic potential and health implications. Nutr Diet Suppl. https:\/\/doi.org\/10.2147\/NDS.S603490","journal-title":"Nutr Diet Suppl"},{"key":"1978_CR76","doi-asserted-by":"publisher","unstructured":"Ravi A, Umapathy S, Pan I (2025) Short-chain fatty acids as a therapeutic strategy in Parkinson\u2019s disease: implications for neurodegeneration. Cell Mol Neurobiol 11\u201328. https:\/\/doi.org\/10.1007\/s10571-025-01609-2","DOI":"10.1007\/s10571-025-01609-2"},{"key":"1978_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1559521","volume":"16","author":"A Safarchi","year":"2025","unstructured":"Safarchi A, Al-Qadami G, Tran CD, Conlon M (2025) Understanding dysbiosis and resilience in the human gut microbiome: biomarkers, interventions, and challenges. Front Microbiol 16:1559521. https:\/\/doi.org\/10.3389\/fmicb.2025.1559521","journal-title":"Front Microbiol"},{"key":"1978_CR78","doi-asserted-by":"publisher","unstructured":"Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EM, Sanders ME, Shamir R, Swann JR, Szajewska H, Vinderola G (2021) The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat reviews Gastroenterol Hepatol 9649\u2013667. https:\/\/doi.org\/10.1038\/s41575-021-00440-6","DOI":"10.1038\/s41575-021-00440-6"},{"issue":"5","key":"1978_CR79","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1515\/revneuro-2016-0068","volume":"28","author":"H Sanjari Moghaddam","year":"2017","unstructured":"Sanjari Moghaddam H, Zare-Shahabadi A, Rahmani F, Rezaei N (2017) Neurotransmission systems in Parkinson\u2019s disease. Rev Neurosci 28(5):509\u2013536. https:\/\/doi.org\/10.1515\/revneuro-2016-0068","journal-title":"Rev Neurosci"},{"key":"1978_CR101","doi-asserted-by":"publisher","unstructured":"Scheperjans F, Levo R, Bosch B, L\u00e4\u00e4peri M, Pereira PA, Smolander OP, Aho VT, Vetkas N, Toivio L, Kainulainen V, Fedorova TD (2024) Fecal microbiota transplantation for treatment of Parkinson disease: a randomized clinical trial. JAMA Neurology 81(9):925\u201338. https:\/\/doi.org\/10.1001\/jamaneurol.2024.2305","DOI":"10.1001\/jamaneurol.2024.2305"},{"issue":"11","key":"1978_CR80","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3390\/biom12111640","volume":"12","author":"E Scott","year":"2022","unstructured":"Scott E, De Paepe K, Van de Wiele T (2022) Postbiotics and their health modulatory biomolecules. Biomolecules 12(11):1640. https:\/\/doi.org\/10.3390\/biom12111640","journal-title":"Biomolecules"},{"issue":"2","key":"1978_CR81","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","volume":"46","author":"M Sharma","year":"2023","unstructured":"Sharma M, Burr\u00e9 J (2023) \u03b1-Synuclein in synaptic function and dysfunction. Trends Neurosci 46(2):153\u2013166. https:\/\/doi.org\/10.1016\/j.tins.2022.11.007","journal-title":"Trends Neurosci"},{"key":"1978_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.736978","volume":"8","author":"E Srinivasan","year":"2021","unstructured":"Srinivasan E, Chandrasekhar G, Chandrasekar P, Anbarasu K, Vickram AS, Karunakaran R, Rajasekaran R, Srikumar PS (2021) Alpha-synuclein aggregation in Parkinson\u2019s disease. Front Med 8:736978. https:\/\/doi.org\/10.3389\/fmed.2021.736978","journal-title":"Front Med"},{"issue":"1","key":"1978_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-025-01179-w","volume":"18","author":"J Sun","year":"2025","unstructured":"Sun J, Lu L, Lian Y, Xu S, Zhu Y, Wu Y, Lin Q, Hou J, Li Y, Yu Z (2025) Sodium butyrate attenuates microglia-mediated neuroinflammation by modulating the TLR4\/MyD88\/NF-\u03baB pathway and microbiome-gut-brain axis in cardiac arrest mice. Mol Brain 18(1):1\u201323. https:\/\/doi.org\/10.1186\/s13041-025-01179-w","journal-title":"Mol Brain"},{"issue":"19","key":"1978_CR84","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.3390\/foods12193579","volume":"12","author":"Z Sun","year":"2023","unstructured":"Sun Z, Zhao Z, Fang B, Hung W, Gao H, Zhao W, Lan H, Liu M, Zhao L, Zhang M (2023) Effect of thermal inactivation on antioxidant, anti-inflammatory activities and chemical profile of postbiotics. Foods 12(19):3579. https:\/\/doi.org\/10.3390\/foods12193579","journal-title":"Foods"},{"key":"1978_CR85","doi-asserted-by":"publisher","unstructured":"Suresh SB, Malireddi A, Abera M, Noor K, Ansar M, Boddeti S, Nath TS (2024) Gut microbiome and its role in Parkinson\u2019s disease. Cureus 16(11). https:\/\/doi.org\/10.7759\/cureus.73150","DOI":"10.7759\/cureus.73150"},{"key":"1978_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.570344","volume":"7","author":"T Teame","year":"2020","unstructured":"Teame T, Wang A, Xie M, Zhang Z, Yang Y, Ding Q, Gao C, Olsen RE, Ran C, Zhou Z (2020) Paraprobiotics and postbiotics of probiotic Lactobacilli, their positive effects on the host and action mechanisms: a review. Front Nutr 7:570344. https:\/\/doi.org\/10.3389\/fnut.2020.570344","journal-title":"Front Nutr"},{"issue":"10","key":"1978_CR87","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2174\/011570159X368923250313045859","volume":"23","author":"SY Tian","year":"2025","unstructured":"Tian SY, Cao X, Liu GJ, Zi Y, Zhu HX, Jiang YM, Lou WW, Fang XX, Shan L, Liu Z, Zhuang QX (2025) Role of the central cholinergic nervous system in motor and non-motor symptoms of Parkinson\u2019s disease. Curr Neuropharmacol 23(10):1232\u201348. https:\/\/doi.org\/10.2174\/011570159X368923250313045859","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"1978_CR88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cmet.2025.10.011","volume":"38","author":"M Van Hul","year":"2026","unstructured":"Van Hul M, Cani PD (2026) From microbiome to metabolism: Bridging a two-decade translational gap. Cell Metabol 38(1):14\u201332. https:\/\/doi.org\/10.1016\/j.cmet.2025.10.011","journal-title":"Cell Metabol"},{"issue":"3","key":"1978_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031230","volume":"28","author":"VE Vera-Santander","year":"2023","unstructured":"Vera-Santander VE, Hern\u00e1ndez-Figueroa RH, Jim\u00e9nez-Mungu\u00eda MT, Mani-L\u00f3pez E, L\u00f3pez-Malo A (2023) Health benefits of consuming foods with bacterial probiotics, postbiotics, and their metabolites: a review. Molecules 28(3):1230. https:\/\/doi.org\/10.3390\/molecules28031230","journal-title":"Molecules"},{"key":"1978_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1582733","volume":"4","author":"G Vinderola","year":"2025","unstructured":"Vinderola G, Benkowski A, Bernardeau M, Chenoll E, Collado MC, Cronin U, Eckhardt E, Green JB, Ipharraguerre IR, Kemperman R, Lacroix C (2025) Postbiotics: a perspective on their quantification. Front Nutr 4:1582733. https:\/\/doi.org\/10.3389\/fnut.2025.1582733","journal-title":"Front Nutr"},{"key":"1978_CR91","doi-asserted-by":"publisher","first-page":"11P795735251388","DOI":"10.1177\/11795735251388781","volume":"17","author":"MH Waseem","year":"2025","unstructured":"Waseem MH, Abideen ZU, Shoaib A, Rehman N, Osama M, Sajid B, Ahmad R, Fahim Z, Ansari MW, Aimen S, Cheema AH (2025) Fecal Microbiota Transplantation for Treatment of Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Cent Nerv Syst Disease 17:11P795735251388781. https:\/\/doi.org\/10.1177\/11795735251388781","journal-title":"J Cent Nerv Syst Disease"},{"issue":"1","key":"1978_CR92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12883-021-02544-7","volume":"22","author":"G Wu","year":"2022","unstructured":"Wu G, Jiang Z, Pu Y, Chen S, Wang T, Wang Y, Xu X, Wang S, Jin M, Yao Y, Liu Y (2022) Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson\u2019s disease patients. BMC Neurol 22(1):13. https:\/\/doi.org\/10.1186\/s12883-021-02544-7","journal-title":"BMC Neurol"},{"key":"1978_CR93","doi-asserted-by":"publisher","unstructured":"Xue W, Zhang J, Li Y (2023) Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases. Neural regeneration Res 12370\u20132376. https:\/\/doi.org\/10.4103\/1673-5374.371346","DOI":"10.4103\/1673-5374.371346"},{"key":"1978_CR94","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3389\/fnins.2020.00398","volume":"14","author":"TR Yamasaki","year":"2020","unstructured":"Yamasaki TR, Ono K, Ho L, Pasinetti GM (2020) Gut microbiome-modified polyphenolic compounds inhibit \u03b1-synuclein seeding and spreading in \u03b1-synucleinopathies. Front NeuroSci 14:398. https:\/\/doi.org\/10.3389\/fnins.2020.00398","journal-title":"Front NeuroSci"},{"key":"1978_CR95","doi-asserted-by":"publisher","first-page":"1667448","DOI":"10.3389\/fnagi.2025.1667448","volume":"17","author":"LK Yassin","year":"2025","unstructured":"Yassin LK, Skrabulyte-Barbulescu J, Alshamsi SH, Saeed S, Alkuwaiti SH, Almazrouei S, Alnuaimi A, BaniYas S, Aldhaheri D, Alderei M, Shehab S (2025) The microbiota\u2013gut\u2013brain axis in mental and neurodegenerative disorders: opportunities for prevention and intervention. Front Aging Neurosci 17:1667448. https:\/\/doi.org\/10.3389\/fnagi.2025.1667448","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1978_CR96","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/biologics1020006","volume":"1","author":"N Ye\u015filyurt","year":"2021","unstructured":"Ye\u015filyurt N, Y\u0131lmaz B, A\u011fag\u00fcnd\u00fcz D, Capasso R (2021) Involvement of probiotics and postbiotics in the immune system modulation. Biologics 1(2):89\u2013110. https:\/\/doi.org\/10.3390\/biologics1020006","journal-title":"Biologics"},{"key":"1978_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1282431","volume":"13","author":"C Yuan","year":"2023","unstructured":"Yuan C, He Y, Xie K, Feng L, Gao S, Cai L (2023) Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases. Front Cell Infect Microbiol 13:1282431. https:\/\/doi.org\/10.3389\/fcimb.2023.1282431","journal-title":"Front Cell Infect Microbiol"},{"key":"1978_CR98","doi-asserted-by":"publisher","first-page":"114985","DOI":"10.1016\/j.biopha.2023.114985","volume":"164","author":"MA Zhao","year":"2023","unstructured":"Zhao MA, Chu J, Feng S, Guo C, Xue B, He K, Li L (2023) Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review. Biomed Pharmacother 164:114985. https:\/\/doi.org\/10.1016\/j.biopha.2023.114985","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1978_CR99","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-011079","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D (2021) Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9(1):226. https:\/\/doi.org\/10.1186\/s40168-021-011079","journal-title":"Microbiome"},{"key":"1978_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.937555","volume":"13","author":"M Zhu","year":"2022","unstructured":"Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z (2022) Gut microbiota: a novel therapeutic target for Parkinson\u2019s disease. Front Immunol 13:937555. https:\/\/doi.org\/10.3389\/fimmu.2022.937555","journal-title":"Front Immunol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01978-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01978-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01978-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:35:09Z","timestamp":1788924909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01978-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1978"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01978-7","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"210"}}